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Rare diseases (RDs) or orphan diseases are a group of
diseases with a low prevalence (less than 5 persons per
10.000 individuals). There are about 1000 currently
recognised RDs from assumed 6000-8000 ones. Almost
80% of RDs have a genetic origin with symptoms
appearing in prenatal and early postnatal periods. Due
to the wide spectrum of RDs and a lack of sufficient
knowledge about individual RDs, the correct diagnosis is
difficult to make. Furthermore, currently there are no
appropriate treatment approaches for most of the RDs.
Due to the molecular background of most RD patholo-
gies, it is expected that the multimodal approach
(*omics, pharmacogenetics, medical imaging, etc.) with
multidisciplinary professionals should be instrumental
for the ‘‘personalisation’’ to diagnose individual RDs, to
create effective preventive measures and to develop tar-
geted therapies. Recent achievements in bio/medical
sciences let us trust in a prompt translation of innova-
tive technologies into daily clinical practice. In order to
increase the impact of personalized medicine, education
at the level of all stakeholders is needed. One aspect
that should be taken into consideration is the very fast
advances in the technologies that are used and the
information dissemination that is lagging behind. The
stakeholders can be numerous in the area of health care
and education and awareness raising should be done at
a wide spectrum such as general public, policy makers,
nurses, genetic counsellers, ethics review committees.
Within the concept for education for all, I would also
like to draw the attention to the technological gap that
exists between countries that innovate and develop the
technologies and the less developed countries where the
technology transfer is at a high cost and human capabil-
ities, critical mass and the physical infrastructure is not
sufficient. Looking towards Horizon 2020, it may be a
good opportunity to take up the area of education and
information dissemination as one of the goals of the
new program. A global approach to form networks
between developed and less developed countries will
definitely benefit all patients in the long run. The
European Association for Predictive, Preventive and
Personalised Medicine (EPMA) actively promotes the
scientific and technological efforts, expert recommenda-
tions and creation of new guidelines in the field of RD
healthcare. This initiative has been triggered through
The EPMA Journal launched in 2010 as the professional
forum in PPPM. The new book “Rare Diseases: Integra-
tive PPPM Approach as the Medicine of the Future” is
dedicated to all aspect related to the prediction, preven-
tion and personalised treatments of RDs. This volume is
intended to serve as a reference source for scientific and
medical centres involved in the field with a special
emphasis on healthcare promotion and innovations
intended to combat RDs. This book can be used as edu-
cation material; it has a wide range of chapters from
emerging diagnostic methods, biobanking, iPScell tech-
nologies to genetic therapies. Hopefully it can also find
high circulation in developing countries to be used as
lecture material in graduate and postgraduate curricula.
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